There is a growing body of evidence to suggest that mutations in neuroblastoma ras viral oncogene homolog (N-RAS) and v-raf murine sarcoma viral oncogene homolog B (BRAF), both activators of mitogen-activated protein kinase (MAPK-ERK), are involved in melanoma development [46,47]. Here, BRAF is linked to melanoma.